Marvellous Medicine
Analysis14 Kesä 2021

Marvellous Medicine

Most of us were blindsided by the novel virus SarsCov2, but infectious disease experts had been warning about the possibility of a global pandemic for some years. For them it was never a matter of if, but when. What did come as a surprise was the speed of scientific progress to fight Covid 19. The first effective vaccine, from Pfizer/BioNTech, was developed in under 300 days, followed in successive weeks by Moderna and Oxford/AstraZeneca. The results of the UK’s RECOVERY trial, which was organised in a matter of weeks, has saved an estimated million lives worldwide by identifying which treatments are effective in treating Covid 19. And regulators around the globe, like Britain’s MHRA, are using innovative programmes to get medical products to people faster. During the pandemic, the world witnessed how fast medicine can advance with an abundance of cash and collaboration. Is progress at this speed and cost sustainable? Sandra Kanthal asks if drug development is something which should still take decades, or have we learned how to permanently accelerate the process?

Guests:

Rod MacKenzie, Chief Development Officer, Pfizer Nuala Murphy, President Clinical Research Services, Icon Professor Sir Martin Landray, Co-Chief Investigator, RECOVERY Trial Nicholas Jackson, Head of Programmes and Technology, CEPI Christian Schneider, Interim Chief Scientific Officer, MHRA Hilda Bastian, Independent Scientist

Producer and Presenter Sandra Kanthal Editor Jasper Corbett

Jaksot(389)

Who Speaks for the Workers?

Who Speaks for the Workers?

Union membership is in decline whilst structural changes in the economy - including the rise of the so-called gig economy - are putting downward pressure on wages, and creating fertile conditions for ...

26 Kesä 201728min

Brexit: A Tale of Two Cities

Brexit: A Tale of Two Cities

A year on from the Brexit referendum, Anand Menon contrasts Wakefield, which voted leave, with Oxford which voted remain, to find out how they feel now.

23 Kesä 201728min

What went wrong with Brazil?

What went wrong with Brazil?

During Brazil's boom years the country's rising economy created a new middle class of gigantic proportions - tens of millions escaping from poverty. Brazil felt confident and even rich enough to bid f...

19 Kesä 201728min

Germany - Anxious Giant

Germany - Anxious Giant

With angst over European security growing, why is Germany such a reluctant military power? Chris Bowlby discovers how German pacifism has grown since World War Two. The German army, the Bundeswehr, is...

12 Kesä 201728min

Implicit Bias

Implicit Bias

Do we unconsciously harbour racist and sexist attitudes? Far fewer people are explicitly racist than a couple of decades ago. They won't express or admit to racist sentiments. But what happens beneath...

5 Kesä 201728min

Aid: Something to Boast About?

Aid: Something to Boast About?

Why is the UK such a generous global aid donor and should it be? The coalition government legislated to ensure Britain spent 0.7% of its national income on international development and it is now one ...

30 Touko 201728min

Adventures in Social Mobility

Adventures in Social Mobility

What are the unwritten rules you must learn to get a top job? Hashi Mohamed came to the UK aged nine, as an unaccompanied child refugee, with hardly any English. His academic achievements at school we...

11 Huhti 201737min

Detoxifying France's National Front

Detoxifying France's National Front

Has Front National leader Marine Le Pen really detoxified the party founded by her father 40 years ago? Is it a right-wing protest movement or a party seriously preparing for power? Anand Menon, profe...

20 Maalis 201728min

Suosittua kategoriassa Politiikka ja uutiset

aikalisa
rss-ootsa-kuullut-tasta
tervo-halme
ootsa-kuullut-tasta-2
politiikan-puskaradio
viisupodi
et-sa-noin-voi-sanoo-esittaa
otetaan-yhdet
rss-asiastudio
rss-vaalirankkurit-podcast
rss-podme-livebox
linda-maria
the-ulkopolitist
rss-kaikki-uusiksi
rss-tekkipodi
rikosmyytit
rss-mina-ukkola
rss-kuka-mina-olen
rss-raha-talous-ja-politiikka
rss-kyselytunti